Skip to main content

Chinese President Xi Jinping, also the general secretary of the Communist Party considering whether to extend the effective retirement the age for the party's top leadership


BEIJING -- Chinese President Xi Jinping, also the general secretary of the Communist Party, has begun considering whether to extend the effective retirement age for the party's top leadership, according to some party members.

The current, unwritten retirement age for those in top leadership positions -- which is always tacitly agreed to -- is 68. Pushing back the age limit would allow Xi -- who turns 69 at the end of his 10-year, two-term reign as general secretary in 2020 -- to seek a third term.

The Central Committee's sixth plenary session, an important party meeting, begins on Monday, and the subject is expected to be taken up. A decision would then be finalized at the next National Congress, about a year from now.

Under the party's present rule, five of the seven current members of the Central Politburo Standing Committee will be 68 or older when the National Congress is held. It is expected that they will retire.

Xi and Premier Li Keqiang will stay on. At the following National Congress, in 2022, only Li would remain in the leadership.

Some suspect that the extension plan is motivated by Xi's fear of losing his grip on power.

In Chinese politics, the Communist Party advises the government, with the party's general secretary doubling as the country's president. The constitution limits the tenure of president to two terms, or 10 years. A later retirement age for party leaders would allow Xi to continue wielding power after stepping down as president.
Labels:

Comments

Post a Comment

Popular posts from this blog

First woman president in Namibia

Namibia has its first woman president. Namibians say it won’t mean much for women Namibia’s presidential and National Assembly elections this year have been historic on many fronts. They were the country’s most controversial elections, with accusations of foreign interference and election rigging at the forefront; while the country’s first female president was elected. The South West Africa People’s Organisation’s (Swapo’s) Netumbo Nandi-Ndaitwah was announced as the president-elect on Tuesday night, with 57.69% of the vote. The announcement was made at the Electoral Commission of Namibia’s (ECN’s) headquarters in Windhoek, but many parties were absent — contributing to a sombre mood. Multiple parties, including the incoming official opposition party, the Independent Patriots for Change (IPC), and the Landless People’s Movement (LPM) boycotted the announcement, as they do not recognise the election’s results. In a statement issued moments before the announcement, the IPC reaffirmed its...
Post a Comment
Read more

Tanzani When the earthquake struck, the brick walls simply crumbled at the orphanage in Tanzania

  Tanzani When the earthquake struck, the brick walls simply crumbled at the orphanage in Tanzania's far northwestern Kagera region.Clutching one of the youngest children, Saada Suleiman said she tried to run as Saturday's tremormade the ground heave beneath her feet."I felt something, as though someone was pushing me from behind, and suddenly the building was shaking," said Suleiman, who operates the Uyacho Orphanage Centre in Bukoba township. 
Post a Comment
Read more

HIV treatment is ready for trials

Live news Uploaded at 15:41 5 September 2023 Getty Images Copyright: Getty Images Anti-retroviral therapy trials are expected to begin in Denmark before the end of the year, with a drug that could prove to be a long-awaited cure for the AIDS virus. The results of preliminary laboratory tests carried out by two teams of Australian scientists in collaboration with their colleagues from Denmark are encouraging about the hope of finding a cure. An Australian study clearly shows that the Oncologic drug venetoclax has the ability to detect "cells" in the human body that are adversely affected by the virus. Next year, in addition to Denmark, trials of the drug will also begin in Melbourne, Australia. Meanwhile, pills with the trade name VENCLEXTA were originally developed to fight blood cancer. It was approved in the United States in 2016 and since then, according to doctors, it has already helped thousands of cancer patients. There are currently around 40 million people living with...
Post a Comment
Read more